COMMUNIQUÉS West-GlobeNewswire

Retrieve Medical, Inc. Selected to Exhibit Retrieve Dx(TM) at Vizient Innovative Technology Exchange
04/06/2024
BEDMINSTER, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Retrieve Medical, Inc. is proud to announce that it has been selected to exhibit its groundbreaking AI-driven software, Retrieve Dx, at the prestigious Vizient [...]
Dr. John Q. Cook of the Whole Beauty® Institute Chicago to Present at the International Society of Aesthetic Plastic Surgery World Congress
04/06/2024
Board-Certified Plastic Surgeon Dr. John Q. Cook Will Present at the 28th World Congress on Aesthetic Plastic Surgery in Cartagena, Colombia CHICAGO, June 04, 2024 (GLOBE NEWSWIRE) -- Dr. John Q. Cook of the Whole [...]
Physicians’ Right to Free Speech Upheld in AAPS v. ABIM
04/06/2024
TUSCON, Ariz., June 04, 2024 (GLOBE NEWSWIRE) -- A precedent-setting ruling in favor of the First Amendment was issued today by the U.S. Court of Appeals for the Fifth Circuit. This influential Court established the [...]
Nordic Naturals Joins 40th Annual California Coastal Cleanup to Protect the Health of the Oceans
04/06/2024
WATSONVILLE, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- With its dedication to sustainable practices, Nordic Naturals is proud to announce its participation in the 40th Annual California Coastal Cleanup on Sept. 21, led [...]
BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease
04/06/2024
PITTSBURGH, June 04, 2024 (GLOBE NEWSWIRE) -- BlueSphere Bio , a T-cell receptor (TCR) T-cell therapy company utilizing a powerful TCR discovery platform to identify novel therapeutic candidates for patients with [...]
18 Genesis HealthCare Affiliated Centers Earn 2024 AHCA/NCAL Bronze National Quality Award
04/06/2024
National award signifies a formal commitment to continuous improvement in quality care. KENNETT SQUARE, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- Genesis HealthCare, Inc., one of the largest post-acute providers in the [...]
TytoCare Introduces Major Release to Increase Flexibility and Accessibility of Care Delivery
04/06/2024
Update for TytoCare’s Home Smart Clinic Adds Features to Facilitate Ease-of-Use and Seamless Integration, Ultimately Expanding Care to Thousands More Users NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- TytoCare , a [...]
Floré Clinical Teams Up with Evexia Diagnostics to Distribute Personalized Microbiome Mapping Technology to 20,000 Clinicians
04/06/2024
GI SereniT™ Equips Clinicians and Patients with Clinically Relevant Insight into Their Gut Health and Provides Individualized Solutions SAN DIEGO and WASHINGTON, Conn., June 04, 2024 (GLOBE NEWSWIRE) -- Floré Clinical [...]
Vilya Expands Series A Financing to $71 Million to Advance Computational Drug Design and Develop a New Class of Medicines
04/06/2024
Founder and lead investor ARCH Venture Partners is joined by NVIDIA’s NVentures, Menlo Ventures, and Madrona Funding accelerates advancement of Vilya's proprietary computational drug design and development platform and [...]
Raydiant Oximetry Oversubscribes Series A $7.5 Million Extension Round
04/06/2024
SAN RAMON, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Raydiant Oximetry, Inc ., a clinical-stage medical device company that develops medical technologies to improve outcomes for mothers and babies during childbirth, [...]
Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
04/06/2024
AUSTIN, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced today details of new analyses of data [...]
Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen
04/06/2024
SALT LAKE CITY, June 04, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the addition of a new Universal Plus Panel to its Foresight ® [...]
Deep integration of proven AI tools into Philips cardiovascular ultrasound systems to better diagnose more cardiac disease patients
04/06/2024
June 4, 2024 New FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery [...]
Aviv Clinics Announces Case Study Showing Benefits of Hyperbaric Oxygen Therapy for Military Post-Traumatic Stress Disorder in Elderly Veterans
04/06/2024
Findings underscore the potential of HBOT as a novel therapeutic approach for elderly individuals with persistent PTSD, even decades after the traumatic event ORLANDO, Fla., June 04, 2024 (GLOBE NEWSWIRE) -- Aviv [...]
Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy
04/06/2024
--Results in Performance of the Upper Limb (PUL 2.0) Continue to Show Benefits in Skeletal Muscle Function After 3 Years of CAP-1002 Treatment (p< 0.001)-- --Stabilization in Left Ventricular Ejection Fraction (LVEF [...]
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
04/06/2024
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
04/06/2024
MELVILLE, NY., June 04, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX) , a clinical stage company focused on stem cell-based therapies, today announced that [...]
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
04/06/2024
Predictive Oncology’s organ-specific in vitro models are designed to better mimic the physiological environment of human tissue The 3D cell culture market is projected to grow by more than 14% annually, from $1.4 [...]
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
04/06/2024
SZN-043 is a novel hepatocyte-specific R-spondin mimetic bispecific fusion protein targeting ASGR1 Anticipate potential proof-of-concept data available in the first half of 2025 SOUTH SAN FRANSCISO, Calif., June 04, [...]

Pages